Trial Profile
An Open-label Study to Assess the Safety and Efficacy of Concurrent Administration of Two Injections of AA4500 0.58 mg Into the Same Hand of Subjects With Multiple Dupuytren's Contractures
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2015
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Registrational; Therapeutic Use
- Sponsors Auxilium Pharmaceuticals
- 08 May 2014 According to a Biospecifics Technologies Corporation media release, the supplement biologics license application (sBLA) for potential label expansion of Xiaflex is under FDA review with a PDUFA date of October 20, 2014.
- 18 Oct 2013 New trial record
- 07 Oct 2013 Analysis on the use of local anaesthesia reported in a BioSpecifics Technologies Corporation media release and presented at the 68th Annual Meeting of the American Society for Surgery of the Hand (ASSH).